MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

140.56 -1.12 (-0.79%)
Streaming Delayed Price Updated: 11:30 AM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
News headline image
Workday And Lam Research Lead The QQQ ↗
U.S. indices were trading higher Friday as investors eye Fed Chairman Powell's speech at the Jackson Hole Symposium and gauge Fed tapering policy. The Invesco QQQ Trust... 
Via Benzinga
Topics Economy
News headline image
Illumina’s Shanghai Family Day Educates Kids on DNA and STEM Activities
SOURCE: Illumina 
Via 3BL Media
News headline image
Looking into Illumina's Return on Capital Employed ↗
Pulled from Benzinga Pro data Illumina (NASDAQ:ILMN) showed a loss in earnings since Q1, totaling $187.00 million. Sales, on the other hand, increased by 3.02% to $1.13 billion... 
Via Benzinga
News headline image
Friday Fears and Other Stock News Updates ↗
Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates. 
Via Talk Markets
News headline image
Illumina's Interns Contribute Over 800 Hours on Social Impact Projects
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina slides after 'Confusing' close of Grail deal amid antitrust probe ↗
Citi sees some risk that Illumina's tactic does not sit well with the regulatory bodies. 
Via Talk Markets
News headline image
Somatic Genetic Testing Market to See Thriving Worldwide : Genomics, Illumina, Invivoscribe ↗
Stay up-to-date with Global Somatic Genetic Testing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... 
Via Benzinga
News headline image
Microsoft And Cisco Gain As The QQQ Bounces Back Thursday ↗
U.S. indices bounced back Thursday after falling Wednesday amid macro uncertainty due to COVID-19 delta variant concerns. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained... 
Via Benzinga
News headline image
Why Illumina Stock Just Dropped 10% ↗
The genetic-testing company just blatantly defied its regulators. 
Via The Motley Fool
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial... 
Via Benzinga
News headline image
Illumina Stock Nosedives After DNA Giant Makes A 'Maverick Move' In Its Grail Takeover ↗
Illumina stock tumbled Thursday after the company finished its $8 billion acquisition of Grail despite an ongoing investigation in Europe. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021 ↗
Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ: 
Via Benzinga
News headline image
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process ↗
In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout... 
Via Benzinga
News headline image
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
SOURCE: Illumina 
Via 3BL Media
Topics Death Regulatory Compliance
News headline image
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All 
Via News Direct
Topics Product Recall
News headline image
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
SOURCE: Illumina 
Via 3BL Media
Topics Product Recall
News headline image
Illumina Stock Earns Membership In Elite Club ↗
Illumina saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 93 the day before. 
Via Investor's Business Daily
CD Genomics Launched Viral Genome Sequencing Service to Help Scientists Fight Against Viruses
Via Get News
News headline image
Illumina Coordinates Research and Efforts in China’s Rare Disease Community
Illumina Coordinates Research and Efforts in China’s Rare Disease Community 
Via News Direct
News headline image
Illumina Coordinates Research and Efforts in China’s Rare Disease Community
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina Delivers a Beat and a Raise in Q2 ↗
According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders." 
Via The Motley Fool
Topics Earnings
News headline image
EU Regulators Temporarily Pause Illumina, Grail Deal Investigation ↗
The European Commission has temporarily suspended the provisional deadline for its investigation into Illumina Inc's (NASDAQ: ILMN) plans to buy Grail Inc,... 
Via Benzinga
News headline image
Extending COVID Surveillance Capabilities Beyond Big Cities
With the debut of Illumina's COVIDSeq Assay, smaller labs are participating in Covid-19 surveillance 
Via News Direct
News headline image
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys ↗
Wait for pitches that are easy to hit before taking a swing. 
Via The Motley Fool
News headline image
What Does the Future Look Like for Illumina Stock? ↗
The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight. 
Via The Motley Fool
News headline image
Extending COVID Surveillance Capabilities Beyond Big Cities
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina Donates Next-Generation Sequencing Capabilities to Support Indigenous Scientists
Next-generation sequencing is helping Native nations with sovereignty and genetic research 
Via News Direct
Topics Intellectual Property
News headline image
Illumina Donates Next-Generation Sequencing Capabilities to Support Indigenous Scientists
SOURCE: Illumina 
Via 3BL Media
Topics Intellectual Property
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story